SCHEMBL6101784

SCHEMBL6101784

O=c1ccc2ccc(OCCCCN3CCN(c4cncc5cccnc45)CC3)nc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 19/20 0.64
HTR1A P08908 11/20 0.64
HTR2A P28223 11/20 0.64
DRD4 P21917 4/20 0.42
DRD3 P35462 4/20 0.42
HTR7 P34969 2/20 0.42
HTR6 P50406 2/20 0.42
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
ADRA1B P35368 1/20 0.41
KCNH2 Q12809 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371091 0.90 DRD2 (0.72) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL6108811 0.84 DRD2 (0.61) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL5370235 0.83 HTR1A (0.69) DRD2HTR1AHTR2ADRD3HTR7
SCHEMBL5374803 0.82 DRD2 (0.71) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL5375484 0.82 DRD2 (0.71) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL5367098 0.81 DRD2 (0.76) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL5363742 0.81 DRD2 (0.67) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL4759675 0.81 HTR1A (0.75) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL5378995 0.80 DRD2 (0.87) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL6103085 0.80 DRD2 (0.69) DRD2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006090272-A1 ISOQUINOLINE [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2006-08-31 WO claimed
WO-2006090272-A1 ISOQUINOLINE [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2006-08-31 WO disclosed